Zoetis Inc. (ZTS)

USD 167.01

(-2.21%)

EBITDA Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual EBITDA in 2023 was 3.68 Billion USD , up 17.18% from previous year.
  • Zoetis Inc.'s latest quarterly EBITDA in 2024 Q3 was 955 Million USD , up 2.23% from previous quarter.
  • Zoetis Inc. reported an annual EBITDA of 3.35 Billion USD in 2022, up 4.18% from previous year.
  • Zoetis Inc. reported an annual EBITDA of 3.17 Billion USD in 2021, up 6.85% from previous year.
  • Zoetis Inc. reported a quarterly EBITDA of 955 Million USD for 2024 Q3, up 2.23% from previous quarter.
  • Zoetis Inc. reported a quarterly EBITDA of 1.03 Billion USD for 2024 Q2, up 11.43% from previous quarter.

Annual EBITDA Chart of Zoetis Inc. (2023 - 2009)

Historical Annual EBITDA of Zoetis Inc. (2023 - 2009)

Year EBITDA EBITDA Growth
2023 3.68 Billion USD 17.18%
2022 3.35 Billion USD 4.18%
2021 3.17 Billion USD 6.85%
2020 2.68 Billion USD 22.38%
2019 2.45 Billion USD 7.16%
2018 2.21 Billion USD 14.97%
2017 1.94 Billion USD 21.97%
2016 1.63 Billion USD 41.33%
2015 868 Million USD 2.74%
2014 1.14 Billion USD 14.96%
2013 1.01 Billion USD -16.29%
2012 941 Million USD 23.78%
2011 635 Million USD 72.29%
2010 400 Million USD 44.35%
2009 2 Million USD 0.0%

Peer EBITDA Comparison of Zoetis Inc.

Name EBITDA EBITDA Difference
Amneal Pharmaceuticals, Inc. 500.78 Million USD -635.849%
Bausch Health Companies Inc. 2.88 Billion USD -27.73%
Catalent, Inc. -284 Million USD 1397.535%
Emergent BioSolutions Inc. -505.29 Million USD 829.27%
Elanco Animal Health Incorporated -224 Million USD 1745.089%
Perrigo Company plc 646.2 Million USD -470.257%
Teva Pharmaceutical Industries Limited 4.33 Billion USD 14.955%